The Journal of Pediatrics
Volume 156, Issue 3 , Pages 352-358.e1 , March 2010

Cough in the Pediatric Population

  • Alan B. Goldsobel, MD, FAAP, FAAAAI

      Affiliations

    • Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
    • Allergy and Asthma Associates of Northern California, San Jose, CA
    • Corresponding Author InformationReprint requests: Alan B. Goldsobel, MD, FAAP, FAAAAI, Allergy and Asthma Associates of Northern California, 4050 Moorpark Ave, San Jose, CA 95117.
  • ,
  • Bradley E. Chipps, MD, FAAP, FAAAAI, FCCP

      Affiliations

    • Capital Allergy and Respiratory Disease Center, Sacramento, CA

Received 13 March 2009 ,Revised 23 August 2009 ,Accepted 2 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 A.G. is supported by grants from Aerovance, Altana/Nycomed, Capnia, Clinsys, GSK, Johnson & Johnson, Lev Pharmaceuticals, MAP, Schering Plough, and UCB. A.B. serves as a speaker/consultant for Astra Zeneca, Meda, and Merck and received stock options from Apeiron. B.C. is supported by grants from Alcon, Sanofi-Aventis, Genentech, Astra Zeneca, GlaxoSmithKline, Novartis, Schering Plough, Sepracor, and Merck; serves as a consultant for Alcon, Sanofi-Aventis, Genentech, Astra Zeneca, GlaxoSmithKline, MedPointe, Novartis, Schering Plough, Sepracor, and Merck; and serves on the speaker's bureau for Alcon, Sanofi-Aventis, Genentech, Astra-Zeneca, GlaxoSmithKline, MedPointe, Novartis, Schering Plough, Sepracor, Merck, Boehringer Ingelheim, and Pfizer.

PII: S0022-3476(09)01227-X

doi: 10.1016/j.jpeds.2009.12.004

The Journal of Pediatrics
Volume 156, Issue 3 , Pages 352-358.e1 , March 2010